Department of Ophthalmology, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
Am J Ophthalmol. 2011 Jun;151(6):1095-1100.e1. doi: 10.1016/j.ajo.2010.11.026. Epub 2011 Feb 19.
To search for mutations in the TSPAN12 gene in 90 Japanese probands with familial exudative vitreoretinopathy (FEVR) and their family members and to determine the types and frequencies of the mutations.
Laboratory investigation and clinical case analyses.
Direct sequencing after polymerase chain reaction of the coding exons of TSPAN12 was performed for 90 probands with FEVR and some of their family members. The clinical signs and symptoms that were characteristic of individuals with TSPAN12 mutations were determined.
Three families were found to carry 2 mutations in TSPAN12. One of these mutations was a new missense change, L245P, and the other was an already reported nonsense mutation, L140X, in 2 families. Mutations in TSPAN12 accounted for 3% of Japanese FEVR patients and 8% of the FEVR families who did not have mutations in any of the known FEVR genes, FZD4, LRP5, and NDP. The clinical signs and symptoms varied among the patients, but the retinal findings with TSPAN12 mutations were not different from those with mutations in the known FEVR-causing genes.
Mutant TSPAN12 is responsible for approximately 3% of FEVR patients in Japan. The results provide further evidence that mutations in TSPAN12 are FEVR causing and that the gene products most likely play a role in the development of retinal vessels.
在 90 名日本家族性渗出性玻璃体视网膜病变(FEVR)患者及其家庭成员中寻找 TSPAN12 基因的突变,并确定突变的类型和频率。
实验室研究和临床病例分析。
对 90 名 FEVR 患者及其部分家庭成员的 TSPAN12 编码外显子进行聚合酶链反应后直接测序。确定具有 TSPAN12 突变个体的特征性临床症状和体征。
发现 3 个家族携带 TSPAN12 的 2 个突变。其中一个突变为新的错义改变,L245P,另一个突变为已报道的无义突变,L140X,存在于 2 个家族中。TSPAN12 突变占日本 FEVR 患者的 3%,占未发现任何已知 FEVR 基因(FZD4、LRP5 和 NDP)突变的 FEVR 家族的 8%。患者的临床症状和体征各不相同,但具有 TSPAN12 突变的视网膜表现与已知引起 FEVR 的基因突变并无不同。
突变的 TSPAN12 是日本约 3%的 FEVR 患者的病因。这些结果进一步证明 TSPAN12 突变是 FEVR 的致病原因,该基因产物可能在视网膜血管发育中发挥作用。